President Donald Trump’s White House blindsided senior health officials when it abruptly dropped his pick to lead the Food and Drug Administration, leaving a key Republican senator furious as he warned that Democrats would get the next shot at confirming an FDA chief.
Trump’s decision was so sudden, according to a CNN report, that Heidi Overton’s team first learned about it from Axios, which some in her circle initially insisted had to be a mistake.
“I think she absolutely had the votes,” a person familiar with the matter told CNN. “There wasn’t any indication that she had an issue.”
Just hours before the White House’s “surprise move,” Overton’s team thought it had won over a key holdout, Sen. Josh Hawley (R-MO), with commitments about the FDA’s review of the abortion pill mifepristone, CNN said. Sen. Bill Cassidy (R-LA) told reporters he’d planned to vote for Overton and that she had enough support to clear his panel.
“But hours after striking that deal, the White House dropped Overton’s candidacy — catching senior HHS officials off-guard and angering” Cassidy, who chairs the Senate health committee, according to the network.
“Cassidy was livid over the abrupt withdrawal,” the report added.
Overton’s allies suspect the White House used doubts about her Senate support as cover after Health Secretary Robert F. Kennedy Jr. and new chief of staff Stephen Miller soured on her. Miller’s predecessor, Susie Wiles, had backed Overton.
“She was Susie’s person,” a person familiar with the matter told CNN. “They were definitely rooting for her failure.”
“Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” Cassidy wrote on X.